In 1992 was created Medpace, which is appeared as Corporate Investor. The leading representative office of defined Corporate Investor is situated in the Cincinnati. The fund was located in North America if to be more exact in United States.
The usual cause for the fund is to invest in rounds with 3-4 partakers. Despite the Medpace, startups are often financed by Helix Ventures. The meaningful sponsors for the fund in investment in the same round are Helix Ventures, Lilly Ventures, Daiichi Sankyo. In the next rounds fund is usually obtained by Helix Ventures, Lilly Ventures, Vivo Capital.
The top amount of exits for fund were in 2014. Deals in the range of 10 - 50 millions dollars are the general things for fund. The fund is constantly included in less than 2 deals per year. The high activity for fund was in 2012.
Moreover, a startup needs to be at the age of 1 and less years to get the investment from the fund. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Among the most popular portfolio startups of the fund, we may highlight Coherus Biosciences. Among the most popular fund investment industries, there are Therapeutics, Biotechnology.
Related Funds
Fund Name | Location |
Altplus Inc. | Japan, Toshima |
B5 Capital | - |
elea Foundation for Ethics in Globalization | - |
Gem State Angel Fund | - |
Hongyou Investment | - |
Invent Ventures | California, Santa Monica, United States |
JD Digits | Beijing, Beijing, China |
Kairous Capital | Kuala Lumpur, Malaysia |
Kaupthing Singer & Friedlander | England, London, United Kingdom |
Kellett Investment | Kirkland, United States, Washington |
LiB Consulting | Japan, Tokyo |
Onward Capital | Florida, Pompano Beach, United States |
PL Family & Friends | - |
Raptor Ventures | - |
SR Capital | China, Jiangsu, Suzhou |
Telligent Capital Management | China, Hong Kong, Hong Kong Island |
Venture University | California, San Francisco, United States |
Westcott LLC | Dallas, Texas, United States |
Xinganxian Media Investment | China, Hangzhou, Zhejiang |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
$188M | 14 Jan 2021 | The Netherlands, North Holland, Netherlands | |||
Coherus Biosciences | $61M | 01 Jan 2012 | Redwood City, California, United States | ||
Coherus Biosciences | $1M | 01 Mar 2011 | Redwood City, California, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
$188M | 14 Jan 2021 | The Netherlands, North Holland, Netherlands | |||
Coherus Biosciences | $61M | 01 Jan 2012 | Redwood City, California, United States | ||
Coherus Biosciences | $1M | 01 Mar 2011 | Redwood City, California, United States |